tiprankstipranks
Trending News
More News >
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
US Market
Advertisement

Marker Therapeutics (MRKR) Income Statement

Compare
533 Followers

Marker Therapeutics Income Statement

Last quarter (Q1 2025), Marker Therapeutics's total revenue was $349.10K, a decrease of -71.94% from the same quarter last year. In Q1, Marker Therapeutics's net income was $-4.45M. See Marker Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.59M$ 3.31M$ 9.01M$ 1.24M$ 466.79K
Gross Profit
$ -6.88M$ -7.11M$ 5.32M$ -1.92M$ -18.41M
Operating Expenses
$ 17.71M$ 17.89M$ 19.79M$ 39.48M$ 10.47M
Depreciation and Amortization
$ 0.00$ 2.79M$ 3.68M$ 3.16M$ 1.08M
EBITDA
$ -4.53M$ -11.27M$ -19.79M$ -36.31M$ -27.63M
Operating Income
$ -11.12M$ -14.58M$ -19.79M$ -39.48M$ -28.89M
Other Income/Expenses
$ 437.01K$ 539.16K$ 15.09K$ -2.40M$ 179.74K
Pretax Income
$ -10.68M$ -14.04M$ -19.78M$ -41.88M$ -28.71M
Net Income
$ -10.73M$ -8.24M$ -29.93M$ -41.88M$ -28.71M
Per Share Metrics
Basic EPS
$ -1.19$ -1.93$ -3.58$ -5.47$ -6.10
Diluted EPS
$ -1.19$ -1.93$ -3.58$ -5.47$ -6.10
Weighted Average Shares Outstanding
8.98M 8.81M 8.35M 7.65M 4.70M
Weighted Average Shares Outstanding (Diluted)
8.98M 8.81M 8.35M 7.65M 4.70M
Currency in USD

Marker Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis